Sino Biopharmaceutical is a pharmaceutical company that engages in research, development and pharmaceutical products for treating diseases.
Business Model:
Revenue: $421.4M
Employees: 10,001-999,999
Address: 10 Guanghua Road
City: Hong Kong
State: beijing municipality
Zip: 100026
Country: CN
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&a;D platforms, a line-up of intelligent production and a strong sales system. The Group&s;s products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemical medicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
Contact Phone:
Contact Email:
Listed Exchange:
HKG
IPO Date:
5/23/2003
Ticker Symbol:
1177
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2022 | Generon (Shanghai) Corporation | Venture Round | 70M |
11/2019 | Akeso Biopharma | Series D | 150M |
11/2021 | Treadwell Therapeutics | Series B | 0 |
12/2020 | Sinovac Life Sciences | Corporate Round | 0 |
8/2021 | XtalPi | Series D | 0 |
8/2015 | LifeBond | Series D | 0 |
12/2021 | Medlinker | Series E | 0 |
6/2022 | Generon (Shanghai) Corporation | Venture Round | 0 |
12/2021 | Medlinker | Series E | 0 |
11/2021 | Treadwell Therapeutics | Series B | 0 |
8/2021 | XtalPi | Series D | 0 |
12/2020 | Sinovac Life Sciences | Corporate Round | 0 |
11/2019 | Akeso Biopharma | Series D | 0 |
8/2015 | LifeBond | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|